This statistic depicts the cost of developing a new drug in the United States from the 1970s to the early 2010s. In the 1970s, the cost of developing a new pharmaceutical drug stood at approximately 179 million U.S. dollars.
- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharmaceuticals: cost of drug development in the U.S. since 1975
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
Exclusive Premium Statistic
This statistic depicts the cost of developing a new drug in the United States from the 1970s to the early 2010s. In the 1970s, the cost of developing a new pharmaceutical drug stood at approximately 179 million U.S. dollars.
| Cost in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| Cost in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic depicts the cost of developing a new drug in the United States from the 1970s to the early 2010s. In the 1970s, the cost of developing a new pharmaceutical drug stood at approximately 179 million U.S. dollars.
Show more- Show sources information
- Show publisher information
- Release date
- July 2018
- Region
- United States
- Survey time period
- 1975 to 2016
- Supplementary notes
-
PhRMA stands for Pharmaceutical Research and Manufacturers of America.
* Including the cost of failures.
** Previous research by the same author estimated average R&D costs in the early 2000s at $1.2 billion in constant 2000 dollars (see DiMasi JA, Grabowski, HG. The cost of biopharmaceutical R&D: is biotech different? Manage Decis Econ. 2007;28:469-479). That estimate was based on the same underlying survey as the author’s estimates for the 1990s to early 2000s reported here ($800 million in constant 2000 dollars), but updated for changes in the cost of capital.
More information
- Region
- United States
- Survey time period
- 1975 to 2016
- Supplementary notes
-
PhRMA stands for Pharmaceutical Research and Manufacturers of America.
* Including the cost of failures.
** Previous research by the same author estimated average R&D costs in the early 2000s at $1.2 billion in constant 2000 dollars (see DiMasi JA, Grabowski, HG. The cost of biopharmaceutical R&D: is biotech different? Manage Decis Econ. 2007;28:469-479). That estimate was based on the same underlying survey as the author’s estimates for the 1990s to early 2000s reported here ($800 million in constant 2000 dollars), but updated for changes in the cost of capital.
Other interesting statistics
+
+Top pharmaceutical companies located in Canada by revenue 2016
+
+World pharmaceutical sales 2015-2017 by region
+
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
+
+Pfizer's total revenue 2006-2017
+
+Johnson & Johnson's total revenue 2005-2017
+
+2018 list of top U.S. biotech and pharmaceutical companies based on revenue
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Clinical trials
- 92 page/s
- English
- pptx
- Detailed references
Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.Marlene Greenfield
Vice President, Hearst Magazines
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*World pharmaceutical market distribution by submarket 2014-2017
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*World pharmaceutical sales 2015-2017 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018Leading countries in life sciences sector M&As 2018
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
The most important statistics
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2017
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)Pfizer's total revenue 2006-2017
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)Merck & Co - total revenue 2006-2017
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014R&D expenditure per employee in U.S. sectors 2000-2014
- Generics
The most important statistics
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*Spending change on branded and generic medicines in the U.S. 2013-2017
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2021
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Popular Related Keywords
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Value of expiring patents in U.S. 2016-2019
- Americans' impression of the US pharma industry quality of drugs, by ethnicity 2017
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Sales growth changes of patented drugs in Canada 2017
- Patented drug 2017 sales share distribution by year of product introduction
- Patent drug sales impact on change in expenditure by therapy class in Canada 2017
- Rate of price change for patented drugs 2017, by country
- Canada 's global sales share of patented drugs 2005-2017
- U.S. top 10 prescribed drugs based on market share 2016
- Top specialty drug pharmacies in the U.S. by revenue 2017
- Patent applications for genetic drugs worldwide 2010
- Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2017
- Expenditure worldwide on diabetes by market 2013-2018
- Definition of specialty drugs by PBMs and pharmacy executives 2011
- Revenues of top diversified products of Valeant Pharmaceuticals U.S. 2017
- Italy: growth rate of advanced dressings market value 2017-2018, by segment
- R&D expenditure of Roche in Spain 2009-2015
- Manufacture of basic pharmaceutical products revenue in Hungary 2010-2022
- Spain: pharmaceutical goods export value 2012-2017
- Revenue market share of acne treatments sold in Spain by company 2018
Studies
- Biotechnology Industry in Europe
- Unleashing Pharma from the R&D Value Chain
- Global Participation in Clinical Trials Report 2015-2016
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Pharmaceutical industry in China
- Pharmaceutical industry in Japan
- The Controversey over Rising Drug Prices: The Public's View
- The Changing Face of Global Clinical Trials
- 2018 PhRMA Annual Membership Survey
- Life Sciences Outlook United States 2017
- Pharmaceutical industry in Italy
- Antibiotic use in the United Kingdom (UK)
- Putting the Science back into Life Sciences
- The 2018 Genentech Oncology Trend Report
- Indicatori Farmaceutici
Statistics on the topic
Free statistics
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Forecast of global medicine spending distribution in 2020, by region*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- How is your overall impression of the U.S. pharma industry?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Reduction in value due to expiring patents in the United States from 2016 to 2019 (in billion U.S. dollars)*
- Opinions on the quality of drugs made by U.S. pharma companies as of 2017, by ethnicity
- Patented drugs quantity changes in Canada between 2015 and 2016, by therapeutic class*
- Patented drugs sales changes in Canada during 2017 (in million Canadian dollars)
- Distribution of Canada's patented drug sales generated in 2017, by year of product introduction
- Patented drug sales impact on changes in expenditure in Canada by therapeutic class in 2017
- Patented drugs average price change in 2017, by country
- Canada's share of global drug sales from 2005 to 2017
- Top 10 prescription drugs based on U.S. market share in 2016 (in billion U.S. dollars)*
- Diabetes spending in developed and pharmerging markets from 2013 to 2018 (in billion U.S. dollars)*
- Share of indications which define a specialty drug as of 2011*
Premium Statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2017, by submarket*
- Global pharmaceutical sales from 2015 to 2017, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2017*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2017 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2017 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2017 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Projected global pharmaceutical sales for 2021, by region (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Top 10 pharmacies based on specialty drug revenue in the U.S. in 2017 (in billion U.S. dollars)
- Number of patent applications for genetically engineered drugs worldwide in 1990 and 2010
- Worldwide sales distribution of new drugs between 2004 and 2017, by major pharmaceutical market
- Revenues of Valeant Pharmaceuticals' top U.S. diversified products in 2017 (in million U.S. dollars)
- Annual growth rate of advanced dressings market value in Italy from 2017 to 2018, by segment*
- Research and development expenditure of Roche in Spain from 2009 to 2015 (in million euros)
- Manufacture of basic pharmaceutical products revenue in Hungary from 2010 to 2022 (in million U.S. dollars)
- Value of pharmaceutical goods exported from Spain from 2001 to 2017 (in 1,000 GBP)
- Revenue market share of acne treatments sold in Spain as of July 2018, by pharmaceutical company
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
News
News
Latest News
Updated
New Digital Market Outlook Reports for 2019
Updates on eCommerce, Digital Media, eTravel, eServices and more
- Market figures for 2018 to 2023
- Company and startup profiles
- User demographics
New
New Dossier: United States coal mining industry
U.S. coal production has steadily declined in the past decade, but has been in the news in recent years due to President Trump's desire to revitalize the industry. This document provides an overview of the key figures, leading companies, and the employment trends in the U.S. coal mining industry.
New
Global Consumer Survey offers PowerPoint export
This new export feature offers
- Structured graphical representation of the data
- Tailored target group analysis
- Option for further processing
New
New Dossier: E-commerce in Poland
The Polish e-commerce market is one of the fastest developing e-commerce markets in Europe. The latest data for Poland is presented in this dossier.
New
New Dossier: Plastic waste in the U.S.
Plastic waste is an issue of global concern. Since China banned the import of recycled plastic, the U.S. has had to make adjustments to its management of plastic waste. This dossier provides an overview of plastic waste in the U.S.
New
New Dossier: Hedge funds
This dossier provides an overview of hedge funds worldwide. Global hedge fund assets, performance, investors, and other topics are highlighted.
New
New exclusive OOH advertising data by OAAA
The Outdoor Advertising Association of America covers amongst others
- Number of billboards
- Outdoor advertising revenue
- Number of out-of-home displays
New
What happens after a no-deal Brexit?
Find data, perceptions & more about
- Economic consequences
- Impact on the labor market
- A second referendum
New
ecommerceDB.com: Ranking update – Spain
Understand the recent developments in the Spanish eCommerce market!
- URL-related revenues
- Relevant online store KPIs
- eCommerce-related contacts
New
Insights into the European banking sector
- Extended statistical dossier
- Insights, explanations & interpretations
- Challenges of the digital future
New
Dossier: Latin American online shopping events
eCommerce is rapidly becoming a part of the Latin American shopping culture. The dossier includes data on
- Regional online shopping events
- Events by country
Updated
Updated Brexit analysis in UK Industry Reports
The outline of potential impacts of Brexit on UK industries has been updated in the UK Industry Reports.
New
New Dossier: Digital Marketing in Italy
Italian enterprises invest significantly in digital marketing. Find out about
- Relevant aspects & KPIs
- New trends
- Different strategies
New
What is football all about, anyway?
Statista European Football Benchmark
- The big 5 European leagues
- All about the clubs & fans
- Sponsors & how they fit in
New
Payment methods in eCommerce
What are online shoppers' payment preferences around the world?
- Data on all payment methods
- Analysis for 50 countries
- Forecasts up to 2023
New
New Dossier: Foreign conflicts of Saudi Arabia
The kingdom of Saudi Arabia has faced political challenges.
- Perceptions & trade information
- Conflicts with Yemen, Iran, Qatar & Turkey
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.